Medical Oncologist
Infusion reactions
Trastuzumab Infusion Reactions — What Happens and How They Are Managed
An infusion reaction during trastuzumab is common, especially the first time. Most reactions are mild and the team manages them while you are still in the chair. A small number are more serious. Knowing the difference means you can act at the right moment.
Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed August 2026
- Most reactions happen during the first infusion — The risk drops with each subsequent dose.
- Mild symptoms are expected and manageable — Chills, low fever and flushing are common and controlled by slowing the drip.
- Breathing difficulty is the key red flag — Tell the nurse immediately — do not wait to see if it settles.
- You are observed for this reason — The monitoring period after the infusion exists specifically to catch delayed reactions.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Infusion reactions to trastuzumab are common, especially during the first dose. Most are mild: chills, fever, or flushing. The team manages these by slowing or pausing the drip. Reactions that involve breathing difficulty, throat tightening, or collapse are rare but need immediate action from the staff administering your infusion.
How do mild and serious reactions differ?
| Sign | Mild — team monitors and adjusts | Serious — requires immediate action |
|---|---|---|
| Fever or chills | Common; usually settles when drip is slowed | Persists or worsens despite pausing the infusion |
| Breathing | Slightly breathless, improves quickly | Cannot complete a sentence; worsening despite pause |
| Skin | Flushing, mild rash, itching | Hives spreading rapidly, or swelling of face and lips |
| Blood pressure | Mild drop; stable when lying down | Sharp drop with dizziness or near-collapse |
| Chest tightness | Mild; resolves when drip is slowed or paused | Severe or accompanied by pain; does not improve |
| Typically starts | Within the first 30–90 minutes of the first infusion | Same window, though severe reactions can evolve quickly |
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Not sure whether this counts as an emergency?
Call the helpline. It is always better to check than to wait.
What does the team do when a reaction starts?
The first step is almost always to slow or pause the drip. For most mild reactions, this is enough to allow the symptoms to settle.
Your team may give paracetamol or an antihistamine to ease fever and itching. In many centres these are given before the infusion starts precisely to reduce the chance of a reaction.
Once symptoms have settled, the infusion can often be restarted at a lower rate. You will be monitored until the full dose is complete and for a period afterwards.
If a reaction is severe, the infusion is stopped for that session. Your oncologist will then decide whether and how to continue trastuzumab — often under closer monitoring or with a revised premedication plan.
What should you watch for after you go home?
Most reactions happen during the infusion or within the first hour of completing it, which is why you stay for observation. Delayed reactions occurring hours later are uncommon but possible after the first dose.
At home, watch for any return of breathing difficulty, swelling, dizziness, or a rash that is spreading. Any of these means going to the nearest emergency department rather than waiting for a call back.
By the second and third infusion, your team will have a clearer picture of how you respond, and the risk of a significant reaction is substantially lower. Many people receive trastuzumab for months or years without further reactions after the first dose.
Explore 75 more Breast Cancer Targeted Medicines topics
Drug Deep Dive: Trastuzumab (Herceptin)
- Adjuvant Trastuzumab: Why Exactly 12 Months After Surgery?
- Diet and Nutrition While on Trastuzumab
- Drug, Food and Supplement Interactions With Trastuzumab
- Fatigue, Chills and Flu-Like Symptoms After a Trastuzumab Infusion
- Fertility, Pregnancy and Contraception on Trastuzumab
- Heart Function and Trastuzumab: Understanding Your ECHO Reports
- Herceptin vs Biosimilar Trastuzumab: Are They Really the Same?
- How Does Trastuzumab Work? The Anti-HER2 Monoclonal Antibody Explained
- How Long Does Trastuzumab Take to Work?
- How Long Will You Stay on Trastuzumab?
- Subcutaneous Trastuzumab vs IV Infusion: Which Suits You Better?
- Tests and Monitoring While You Are on Trastuzumab
- Trastuzumab (Herceptin and biosimilars): The Complete Patient Guide
- Trastuzumab Infusion Day: Premedication, Duration and What to Expect
- Trastuzumab Infusion Reactions: What Happens and How They're Managed
- Trastuzumab Myths: 'It's Chemotherapy' and Other Misunderstandings
- Trastuzumab Price in India: Innovator, Biosimilar and Cost Per Cycle
- Trastuzumab Side Effects: The Complete List and Timeline
- Trastuzumab Success Rate and Survival: An Honest Look at the Numbers
- Trastuzumab With Pertuzumab, Chemotherapy and Hormone Therapy
- Trastuzumab in Elderly Patients and Those With Other Illnesses
- When Trastuzumab Stops Working: Resistance and What Comes Next
- Who Is Eligible for Trastuzumab? HER2-Positive Breast and Gastric Cancer
- Will Insurance or a Government Scheme Pay for Trastuzumab?
- Work, Travel and Daily Life on Trastuzumab
Drug Deep Dive: Palbociclib (Ibrance)
- Diet and Nutrition While on Palbociclib
- Drug, Food and Supplement Interactions With Palbociclib
- Fatigue on Palbociclib: Why It Happens and What Genuinely Helps
- Fertility, Pregnancy and Contraception on Palbociclib
- How Does Palbociclib Work? The CDK4/6 Inhibitor Explained
- How Long Does Palbociclib Take to Work?
- How Long Will You Stay on Palbociclib?
- Low White Cell Count on Palbociclib: Expected, and Rarely Dangerous
- Mouth Sores and Infection Risk on Palbociclib
- Palbociclib (Ibrance, Palbace): The Complete Patient Guide
- Palbociclib Myths: Low Counts, Hair Loss and Stopping Early
- Palbociclib Price in India: Brand, Generic and Monthly Cost
- Palbociclib Side Effects: The Complete List and Timeline
- Palbociclib Success Rate and Survival: An Honest Look at the Numbers
- Palbociclib With Letrozole or Fulvestrant: Understanding Your Combination
- Palbociclib in Early Breast Cancer: Why It Is Not Given After Surgery
- Palbociclib in Elderly Patients and Those With Other Illnesses
- Palbociclib vs Ribociclib vs Abemaciclib: Which CDK4/6 Inhibitor?
- Taking Palbociclib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Palbociclib
- The 21-Days-On, 7-Days-Off Palbociclib Cycle Explained
- When Palbociclib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Palbociclib? Hormone-Receptor-Positive, HER2-Negative Breast Cancer
- Will Insurance or a Government Scheme Pay for Palbociclib?
- Work, Travel and Daily Life on Palbociclib
Drug Deep Dive: Trastuzumab Deruxtecan (Enhertu)
- Diet and Nutrition While on Trastuzumab Deruxtecan
- Drug, Food and Supplement Interactions With Trastuzumab Deruxtecan
- Enhertu Myths: 'It's Just Stronger Herceptin' and Cost Misconceptions
- Enhertu in Breast, Gastric and Lung Cancer: One Drug, Three Diseases
- Fertility, Pregnancy and Contraception on Trastuzumab Deruxtecan
- HER2-Low Breast Cancer: How Enhertu Created an Entirely New Patient Group
- How Does Trastuzumab Deruxtecan Work? The HER2-Directed Antibody-Drug Conjugate Explained
- How Long Does Trastuzumab Deruxtecan Take to Work?
- How Long Will You Stay on Trastuzumab Deruxtecan?
- Interstitial Lung Disease on Enhertu: The Side Effect That Needs Immediate Action
- Low Blood Counts, Hair Loss and Heart Monitoring on Enhertu
- Nausea and Vomiting on Trastuzumab Deruxtecan: Managing a High-Risk ADC
- Tests and Monitoring While You Are on Trastuzumab Deruxtecan
- Trastuzumab Deruxtecan (Enhertu): The Complete Patient Guide
- Trastuzumab Deruxtecan Infusion Day: Premedication, Duration and What to Expect
- Trastuzumab Deruxtecan Price in India: Innovator, Biosimilar and Cost Per Cycle
- Trastuzumab Deruxtecan Side Effects: The Complete List and Timeline
- Trastuzumab Deruxtecan Success Rate and Survival: An Honest Look at the Numbers
- Trastuzumab Deruxtecan in Elderly Patients and Those With Other Illnesses
- Trastuzumab Deruxtecan vs T-DM1 and Trastuzumab: How ADCs Differ
- When Trastuzumab Deruxtecan Stops Working: Resistance and What Comes Next
- Where Trastuzumab Deruxtecan Fits Alongside Chemotherapy and Hormone Therapy
- Who Is Eligible for Trastuzumab Deruxtecan? HER2-Positive and HER2-Low Breast, Gastric and Lung Cancer
- Will Insurance or a Government Scheme Pay for Trastuzumab Deruxtecan?
- Work, Travel and Daily Life on Trastuzumab Deruxtecan
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
Is an infusion reaction the same as an allergy to trastuzumab?
Not exactly. Most infusion reactions are not true allergies. They are a response to the speed or volume of the infusion rather than the drug itself, which is why slowing the drip usually settles them. A true allergy involves the immune system reacting to the drug regardless of infusion rate and is far less common. Your team will note how you responded and classify the reaction, which informs how your next infusion is managed.
Will I react every time I have trastuzumab?
Most people do not. The first infusion carries the highest risk; subsequent infusions are generally better tolerated, and many people complete months of treatment without any further symptoms. If you did react during your first infusion, your team will premedicate you more carefully and infuse more slowly the next time, which substantially reduces the risk of a repeat reaction.
Can trastuzumab be continued if I have had a reaction?
In most cases, yes. A mild or moderate reaction does not usually mean treatment is stopped. Your oncologist will review what happened, adjust the premedication, and may slow the infusion rate for future doses. Severe reactions are assessed individually, and the decision to continue depends on how serious the reaction was and how well it resolved. Most people are able to continue after a mild or moderate reaction.
Why do I need to stay for observation after the infusion finishes?
Reactions most commonly happen during the infusion, but they can also occur in the period immediately afterwards. Staying for observation allows your team to catch and treat a delayed reaction while you are still in a setting where they can act quickly. The monitoring period is typically longer after your first infusion than after later ones. If you feel unwell at any point during observation, tell the nurse rather than waiting.
What should I tell the emergency department if I feel unwell after going home?
Tell them you received a trastuzumab infusion and when it was given. Bring any paperwork from the day-care unit if you can, or the name of the drug and the centre that administered it. Emergency teams need to know the timing and the drug to assess and treat you appropriately. If your oncology team gave you a treatment summary card, keep it with you on infusion days.